Duration of Oxaliplatin-Containing Adjuvant Therapy for Stage III Colon Cancer (beta)
Based on guidelines from the American Society of Clinical Oncology.
Strength
Strong recommendation
Moderate recommendation
Weak recommendation
Evidence
High quality evidence
Intermediate quality evidence
Low quality evidence
Insufficient evidence
N/A